Chang, L., Leng, C., Yeh, Y., Wu, C., Chen, H., Huang, H., & Liu, S. (2014). Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy. BioMed Central.

Chang, Li-Sheng, Chih-Hsiang Leng, Yi-Chen Yeh, Chiao-Chieh Wu, Hsin-Wei Chen, Hai-Mei Huang, and Shih-Jen Liu. Toll-like Receptor 9 Agonist Enhances Anti-tumor Immunity and Inhibits Tumor-associated Immunosuppressive Cells Numbers in a Mouse Cervical Cancer Model Following Recombinant Lipoprotein Therapy. BioMed Central, 2014.

Chang, Li-Sheng, et al. Toll-like Receptor 9 Agonist Enhances Anti-tumor Immunity and Inhibits Tumor-associated Immunosuppressive Cells Numbers in a Mouse Cervical Cancer Model Following Recombinant Lipoprotein Therapy. BioMed Central, 2014.